All Type of News
Caduet frequently troubles in quantity, complained by pharmacies
The Pfizer Pharmaceuticals Korea’s hypertension and hyperlipidemia therapy, Caduet, has recently created gossips among pharmacists.
Moreover, as defective drugs have been found, it has created difficulties in prescri...
Adjustment period changed to ‘2 years’ in market price system
The implementation date of the revised market price system is expected to start in the first half of 2018.
The Ministry of Health and Welfare recently gave an administrative notice of the ‘Partial Amendment to the Ph...
Forxiga’s acute renal impairment warning added in Korea too
Acute renal impairment will be added in approval standards of antidiabetic SGLT-2 inhibitors, ‘Forxiga(dapagliflozin)’ and ‘Invokana(canagliflozin).’
According to the Ministry of Food and Drug Safety(MFDS) on the 22n...
Which company did well over launching new drugs in first half?
When it comes to new drug launches made by multinational pharmaceutical companies in the first half of the year, Boehringer Ingelheim Korea and Lilly Korea were known to lead, and the most common one was anticancer dr...
About 141 thousand breast cancer patients increased by 7.8% annually
The number of patients treated by hospitals and clinics for breast cancer has increased annually by 7.8%, making the total 141,379 people last year.
According to the analysis result of the National Health Insurance C...
81% of doctors, “I will vaccinate my family against shingles”
8 of 10 doctors(81.3%) answered they did or will vaccinate their families against shingles. Since 7 of 10 doctors(71.5) answered they did or will vaccinate themselves against the disease, it has shown high interests i...
Innov. drug companies make annual sales of KRW 414 million per person
The average annual sales per employee working in innovative pharmaceutical companies was KRW 414 million, the foreign pharmaceutical companies Sanofi-Aventis Korea was aggregated to make the most, KRW 760 million, in ...
KSHP’s investigation on multinational pharmaceutical companies’ out-of-stock crisis
Over the multinational pharmaceutical companies’ out-of-stock crisis, the Korean Society of Health-system Pharmacists(KSHP) has shown a move to conduct investigation.
The KSHP(President Kwang-sup Lee) plans to conduc...
Supreme Court remands original trial “dentists can perform Botox procedures”
On the 21st, the Supreme Court(Chief Justice Seung-tae Yang of the Supreme Court, Justice Sang-ok Park of the Supreme Court) remanded the 1st and 2nd rulings that ‘the medical activity of dentists to operate Botox pro...
Botulinum toxin market called red ocean starts second round
The domestic botulinum toxin market, which has become a red ocean, has started the second round.
Pharmaceutical companies which have struggled from cutthroat competition have secured differentiated competitiveness no...
